Materials and methods

Fifty
into the medial rectus of the affected eye or in the case of bilateral palsies, the most severely involved eye. In a few instances both medial recti were injected on the same occasion.
These were performed under EMG control as previously described. 3 A total of 101 injections were given. The subsequent management was dependent on the primary indication for toxin injection and falls into two groups (see Fig. 1 ).
Group A A group of 27 patients had injections as an iso lated treatment modality. Four of these have been reported previously. 10 They were all reas sessed within two weeks of the injection to determine the effect and to decide on sub sequent management. In 12 patients it was necessary to give more than one injection before the usefulness of the Botulinum toxin could be determined. Five of these patients had had surgery for their sixth nerve palsy prior to this treatment. These patients fall into one of three categories according to the outcome.
(1) Functional cure: this is defined as a residual phoria, or a tropia corrected with <5 diopters of horizontal prism and satisfactory relief of diplopia.
(2) Unfit for general anaesthetic: these patients were considered unfit for a general anaesthetic and Botulinum toxin was used to maintain alignment, recognising that this was a temporary correction and numerous injec tions would be required. 
Results
Group A Functional Cure (see Table III ). According to our criteria ten patients (37 per cent) obtained a functional cure with the use of Botulinum toxin. Eight patients received a single injec tion, one received three and one received five.
Only one patient had previously had surgery performed-a recesslresect procedure on the affected eye. The duration of the palsy ranged from 1.5 months to seven years. Only one of these ten cases was secondary to trauma. This was the only bilateral case and required three injections.
Case Report: Patient 7
A five year old child developed a right sixth nerve palsy two weeks following otitis media, meningitis and a right mastoidectomy. When first seen she had a sixty prism dioptre esotropia and no abduction of the right eye beyond the midline -4 . Fusion was demonstrable on the synoptophore examination (see Fig. 2a ). After four weeks there was an increas ing esotropia and signs of contracture were evident (see Fig. 2b ). An injection of Botulinum toxin was administered to the right medial rectus under Ket amine anaesthesia six weeks after the onset of the palsy. She became exotropic and developed a right hypertropia. On examination eight months later she had no manifest deviation, normal ocular rotations and full binocular function (see Fig. 2c ).
Unfit for General Anaesthesia. Two patients (7 per cent) are included in this category. Their initial management has been previously reported. iO One is a woman of 67 years with a right sixth nerve palsy thought to be due to hypertension. She suffered from severe bron chiectasis and general anaesthesia was con sidered unwise. Over a period of three years she received seven injections of Botulinum toxin (see Fig. 3 ). The second was a girl of 19 yearswho had an intracranial arterio-venous malformation. Over three years she required thirteen injections of toxin to maintain satis factory alignment. Surgery was eventually per formed under local anaesthesia.
Botulinum Toxin Unhelpful in Further
Management (see Table IV ). Fifteen patients (56 per cent) obtained no lasting benefit from injection and were subsequently managed by surgery in ten cases or occlusion of one eye in five. Seven patients had a single injection, six had two injections, one had three and one had four injections. The duration of the palsies ranged from four months to forty years. Five cases were bilateral and four had had previous surgery. Tables V and VI Case history: Patient 30 A 19-year old man suffered injuries when a fork-lift truck fell on him. He suffered a left sixth nerve palsy and a skull fracture. Sixteen months after the acci dent he had a total left lateral rectus palsy and was unable to achieve binocular single vision even with a face turn. The esotropia measured 25 prism dioptres. He could fuse and had evidence of binocu lar function on synoptophore examination (see Fig.  4a ). His left medial rectus was injected with Bot ulinum toxin and one week later he had a Jensen procedure performed on the left eye, without a medial rectus recession. On the first post operative day he had a 45 prism dioptre exotropia and no hori zontal movement of the left eye. Vertical movement was full. Twelve months later he had no abnormal head posture, cover testing in the primary position revealed a small esophoria and he had some limi tation of left abduction. He had a large field of single binocular vision with some residual diplopia on left gaze (see Fig. 4b ).
Group B (see
Discussion
That Botulinum toxin injection has a place in the management of sixth nerve palsy is certain.
Although accepting that this reported series represents a highly selected population, we were able to obtain significant benefit for 40 of the 55 patients (72 per cent) at some stage in their management. It is useful to look at each of the proposed indications in turn.
The treatment of sixth nerve palsy in the acute phase, although conceptually attractive,
has not yet been studied on a controlled pro spective basis and that it offers any significant advantage to the patient in the long term is uncertain. We have treated only four patients within a six month period following the onset of their palsy (case no. 6, 7, 10, 14). Gre«n betore lett c.yt Fig.4a c.r..n bctorw 1.1t ere Table   VII ). It can be seen that those who obtained a 
